The forecasted mortality rate from Parkinson's Disease in the US suggests a gradual increase between 2024 and 2028. The mortality rate is expected to rise from 14.9 deaths per 100,000 persons in 2024 to 17.3 in 2028. This represents a year-on-year increase of roughly 4% to 4.5% over each subsequent year. Assuming the mortality rate in 2023 was similar to that of 2024, the compound annual growth rate (CAGR) over these five years reveals a persistent upward trend in Parkinson's Disease mortality.
Future trends to watch for include:
- Potential advancements in medical treatment and early detection methods that may affect mortality rates.
- Changes in demographics, such as an aging population, which may influence the prevalence and outcomes of Parkinson's Disease.
- Socioeconomic factors and healthcare access that could alter these projected trends.
